AARIKA GLAWSON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner TAMPA, FL NPI 1538785654
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner FL Astellas Pharma US Inc All categories
General Payments — all program years on this page
$684.59
- Category: General Payments
- Program years: PY2021–2023
- Record count: 16
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $222.93 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $142.94 | 6 |
| Education | $79.99 | 1 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $106.65 | 2 |
| Melinta Therapeutics, Inc. | $49.60 | 2 |
| Merck Sharp & Dohme Corporation | $42.97 | 2 |
| Paratek Pharmaceuticals, Inc. | $23.71 | 1 |
By program year
Records — PY2023 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1002374227 | Paratek Pharmaceuticals, Inc. | $23.71 | 07/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1034151647 | Astellas Pharma US Inc | $26.66 | 06/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1034201201 | Astellas Pharma US Inc | $79.99 | 06/20/2023 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1048560847 | Merck Sharp & Dohme LLC | $21.29 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1048935249 | Merck Sharp & Dohme LLC | $21.68 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1056143667 | Melinta Therapeutics, LLC | $20.21 | 09/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1056150731 | Melinta Therapeutics, LLC | $29.39 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.